Cosmetic Safety Substantiation: Does FDA Require a Specific Test?
FDA does not prescribe one universal test list for cosmetic safety substantiation. The responsible person still needs adequate supporting safety records for the product.
A test package is not the same as a safety conclusion
FDA’s product-testing information explains that manufacturers can use relevant existing safety data and may need additional scientifically sound testing to address gaps. A generic laboratory package is therefore not automatically sufficient, and the absence of a single prescribed test does not remove the safety obligation.
A useful review asks what each item of evidence supports for the actual formulation and use. Keep ingredient identity, concentration, intended exposure, packaging, and reasonably expected use in view. These are practical considerations for planning an assessment; they are not a new FDA checklist.
Organize the evidence around the product
- Identify the exact formula and label version being assessed.
- Link ingredient and supplier information to the assessed materials.
- Explain why existing studies or data are relevant to the formulation and use.
- Identify remaining questions and the rationale for additional work.
- Retain the assessment and supporting records in a retrievable location.
Use qualified expertise for unresolved questions
A report can be technically valid yet answer a different question from the one the business needs resolved. Ask the person assessing safety to explain the relevance and limitations of the evidence. If additional work is recommended, document the question being addressed and how the results will be evaluated.
Do not describe a cosmetic as FDA approved because a private laboratory performed testing, a consultant reviewed a file, or a facility registered. FDA distinguishes cosmetic safety responsibilities from premarket approval and separately regulates color additives.
Keep the assessment connected to changes
As a suggested quality practice, include a safety-impact review when a formula, ingredient source, intended use, or package changes. Avoid treating a file for an earlier formulation as automatic coverage for a later one. The extent of additional work depends on the change and the evidence; this article does not invent a retest interval or a universal testing battery.
Related inspection resources
- Responsibility when manufacturing is outsourced
- Records access and safety documentation
- Cosmetics inspection consulting
Primary sources
Sources reviewed October 20, 2026. The preparation steps above are practical suggestions; the linked regulations and FDA documents define the applicable requirements.